6533b870fe1ef96bd12cf6e4

RESEARCH PRODUCT

Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study.

Gridelli CGallo CCeribelli AVittorio GebbiaGamucci TCiardiello FCarozza FFavaretto ADaniele BGaletta DBarbera SRosetti FRossi AMaione PCognetti FTesta ADi Maio MMorabito APerrone FGeco Investigators

subject

trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancerhttp://hdl.handle.net/10447/16695